Literature DB >> 3149535

Rapid sample throughput for biomedical stable isotope tracer studies.

T Preston1, D C McMillan.   

Abstract

Typical 13C or 15N tracer studies generate large numbers of samples. Instrumentation capable of rapid automated analysis is therefore of importance as a practical alternative to conventional isotope methodology. Although biomedical sample nature is diverse, experimenters often require analysis of substrates and products of particular biochemical pathways. Clearly, reaction products can contain considerably less isotope tracer than precursors. Analytical techniques thus need to accommodate samples of widely varying nature, size and isotope enrichment. In the clinical field, where stable isotopes are increasingly used to study protein, carbohydrate and fat metabolism, analysis of the isotope ratio of a substrate infused into the plasma and a product of its metabolism is often required. Conventional analytical approaches demand access to two mass spectrometers: isotope ratio mass spectrometry (IRMS) for isotope analysis of the relatively large concentrations of low-enrichment metabolic product, and gas chromatography/mass spectrometry (GC/MS) for analysis of the infused substrate often present at high enrichment but low concentration offers a practical alternative to the conventional approaches that is rapid and automatic. In addition to providing a considerably less complex and costly alternative to conventional instrumentation, a single CF-IRMS instrument can also analyse small quantities of low-enrichment metabolites with superior performance than either of the alternative approaches. CF-IRMS is illustrated using results from constant-infusion studies in human protein and fat metabolism which require measurement of the isotope enrichment in submicromolar quantities of plasma substrates together with analysis of larger quantities of their oxidation products, urinary nitrogen and breath CO2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3149535     DOI: 10.1002/bms.1200160142

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  7 in total

1.  Enhanced drug metabolism in young children with cystic fibrosis.

Authors:  A C Parker; P Pritchard; T Preston; R L Smyth; I Choonara
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

2.  Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans.

Authors:  P Vollenweider; L Tappy; D Randin; P Schneiter; E Jéquier; P Nicod; U Scherrer
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

3.  Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test.

Authors:  A C Parker; P Pritchard; T Preston; I Choonara
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

4.  Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer.

Authors:  K C Fearon; D C McMillan; T Preston; F P Winstanley; A M Cruickshank; A Shenkin
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

5.  Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test.

Authors:  A C Parker; T Preston; D Heaf; N R Kitteringham; I Choonara
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

6.  Lack of a significant change in caffeine metabolism in underweight children as determined by the caffeine breath test.

Authors:  K A Oshikoya; H Sammons; K Smith; I Choonara
Journal:  Arch Dis Child       Date:  2015-04-20       Impact factor: 3.791

7.  Effect of Casilan(®) on (13)C-caffeine metabolism in overnight-fasted healthy Nigerian children.

Authors:  Kazeem A Oshikoya; Ken Smith
Journal:  J Pharmacol Pharmacother       Date:  2013-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.